Inhibition of either the FAK or MAPK pathway effectively blocks the enhanced epithelial–mesenchymal transition (EMT) observed in Beas-2B (airway epithelial cells) in vitro and reduces fibrosis in an ovalbumin (OVA)-induced asthma model in vivo [138]. The gene discussed is PTK2; the disease is asthma.